![Oliver Cumming](https://profiles-cardiff.imgix.net/attachments/665?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Oliver Cumming
Timau a rolau for Oliver Cumming
Cynorthwy-ydd Ymchwil – Ystadegau
Trosolwyg
Rwy'n Gynorthwyydd Ymchwil o fewn y CTR. Gweithio gyda gwahanol dimau i hwyluso casglu ac adrodd data cywir ac effeithlon. Cefndir mewn datblygiad gwe pentwr llawn.
Cyhoeddiad
2026
- Lugg-Widger, F. V. et al. 2026. Understanding inequalities in adult social care in Wales: Protocol for the CARE lab linked administrative data study. International Journal of Population Data Science 11 (1)(10.23889/ijpds.v11i1.3393)
- Kotecha, S. J. et al. 2026. Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study - study protocol. BMJ Open 16 (3) e107929. (10.1136/bmjopen-2025-107929)
2025
- Russell, N. H. et al., 2025. Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3 mutated AML. Blood Advances 9 (24), pp.6455-6466. (10.1182/bloodadvances.2025017244)
2023
- Russell, N. et al., 2023. P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial. HemaSphere 7 (S3) e13145db. (10.1097/01.HS9.0000968844.13145.db)
Erthyglau
- Lugg-Widger, F. V. et al. 2026. Understanding inequalities in adult social care in Wales: Protocol for the CARE lab linked administrative data study. International Journal of Population Data Science 11 (1)(10.23889/ijpds.v11i1.3393)
- Kotecha, S. J. et al. 2026. Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study - study protocol. BMJ Open 16 (3) e107929. (10.1136/bmjopen-2025-107929)
- Russell, N. H. et al., 2025. Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3 mutated AML. Blood Advances 9 (24), pp.6455-6466. (10.1182/bloodadvances.2025017244)
- Russell, N. et al., 2023. P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial. HemaSphere 7 (S3) e13145db. (10.1097/01.HS9.0000968844.13145.db)
Bywgraffiad
- Dadansoddwr Data.
- CONSCOP2
- SAMADICITY name (optional, probably does not need a translation
- BALŴN
- AML19v2
- Gweithiodd fel datblygwr gwe IS&DD. Gweithio i ddarparu systemau cipio data electronig ar gyfer treialon.
- THESEUSConstellation name (optional)
- Healthwise Wales
- SLUMBRS2
- AML17 a AML18PILOT
- CONSCOP2
Ymgysylltu
ArrayContact Details
[email protected]
+44 29225 11688
Neuadd Meirionnydd, Llawr 5, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4YS
+44 29225 11688
Neuadd Meirionnydd, Llawr 5, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4YS
Themâu ymchwil
Arbenigeddau
- Systemau cronfa ddata
- Arolygon, holiaduron a chasglu data meintiol
- Treialon Clinigol
- Rhaglennu